Acquired Immunodeficiency

Aug 19, 2024 | sti.bmj.com | Stefano Rusconi |Giovanni Villa |Tropical Diseases |Acquired Immunodeficiency

Cefixime + doxycycline is less effective against pharyngeal gonorrhoea than ceftriaxone + azithromycinIn a randomised controlled trial, 161 patients diagnosed with uncomplicated urogenital, rectal or pharyngeal gonorrhoea were treated with either single-dose cefixime (800 mg) plus doxycycline (100 mg two times per day for 7 days) or single-dose ceftriaxone (1 g) plus single-dose azithromycin (2 g). At week 1, both treatment arms achieved 100% microbiological clearance.